SB
Sanjay Bhagwant Prabhu
About Sanjay Bhagwant Prabhu
Data last updated:
Sanjay Bhagwant Prabhu is a Director at Neoplus Criticare Private Limited (since 2003). The company operates in Healthcare. Neoplus Criticare Private Limited reported revenue of ₹2.15 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neoplus Criticare Private Limited U85100MH2003PTC140952 | Director | 18 Jun 2003 | 2003 | ₹2.15 Cr (FY 2024) | Active |
Board colleagues of Sanjay Bhagwant Prabhu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Charu Suraiya | 00735144 | Neoplus Criticare Private Limited | Director |
| Devang Kalyanbhai Shah | 00735113 | Neoplus Criticare Private Limited | Director |
| Kamlesh Kumar Shrivastava | 00726778 | Neoplus Criticare Private Limited | Director |
| Mukund Chandulal Patel | 00735080 | Neoplus Criticare Private Limited | Director |
| Prashant Ramesh Gandhi | 00735155 | Neoplus Criticare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Bhagwant Prabhu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Bhagwant Prabhu
Sanjay Bhagwant Prabhu currently holds 1 directorship: Neoplus Criticare Private Limited (Director, since 18 Jun 2003, revenue ₹2.15 Cr (FY 2024)).
Sanjay Bhagwant Prabhu was first appointed on 18 Jun 2003 as Director at Neoplus Criticare Private Limited.
The current boards of Sanjay Bhagwant Prabhu's companies include Charu Suraiya (Neoplus Criticare Private Limited), Devang Kalyanbhai Shah (Neoplus Criticare Private Limited), Kamlesh Kumar Shrivastava (Neoplus Criticare Private Limited), Mukund Chandulal Patel (Neoplus Criticare Private Limited), Prashant Ramesh Gandhi (Neoplus Criticare Private Limited).